How can new diagnostic methods contribute in healthcare? What are doctors looking for? Better support in their clinical decision makings, which includes:

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.
Advertisements

Respiratory tract infections - antibiotic prescribing
Preventable Hospitalizations: Assessing Access and the Performance of Local Safety Net Presented by Yu Fang (Frances) Lee Feb. 9 th, 2007.
Estimating the Global Health Impact of Improved Diagnostic Tools Jeffrey Wasserman Federico Girosi Emmett Keeler November 2006, April 2007.
Doç. Dr. Nurver Turfaner Department of Family Medicine.
1 Acute Cough Definitions of Lower Respiratory Tract Infections (LRTI), ranging in severity: Acute bronchitis - an acute respiratory tract infection in.
CMS Core Measures Evidence-Based Performance Measurement.
High Sensitivity Troponin
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Study: Statins increase life expectancy Detroit News, Associated Press
SORE THROAT & OTITIS MEDIA
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
An innovative community based Cardiac Diagnostics Service prevents hospital attendances PG. Nolan1, O. Harrington2, J. Barton3, BD. MacNeill1, JJ. Crowley1,
The Contribution of Mental Health Services to Tackling Health Inequalities Dr Alastair Cook Chair RCPsych in Scotland.
Healthy Aging & Participating in Research. Discoveries from research led to the medicines and treatments we take for granted today: Vaccines to prevent.
IN THE NAME OF GOD By: Dr malek. References Am J Clin Pathol. 2008;130(5): © 2008 American Society for Clinical Pathology Bryant J, Picot J,
From needs to priorities. Using a Delphi technique to prioritise the IPCRG Research Needs Statement Osman Yusuf Mike Thomas Anders Ostrem Ioanna Tsiligianni.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Biochemical Markers of Myocardial Infarction
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Prognostic Utility of Secretory Phospholipase A 2 in Patients with Stable Coronary Artery Disease M. O'Donoghue, Z. Mallat, D.A. Morrow, J. Benessiano,
Patient education tools are key to the follow- up of chronic heart failure patients.
A view of Novel Cardiac Biomarkers in Heart Failure.
The Value Of In-vitro Diagnostics Healthcare challenges in the 21 st century for governments & hospitals & how in-vitro diagnostics can contribute to overcoming.
Pattern of Diabetes Emergencies among adult Yemeni Diabetic Patients Dr. Zayed Atef Faculty of Medicine Sana’a University.
Economic Burden and Health Consequences of Antibiotic Resistance in Patients at a Tertiary Care Hospital, Vellore, South India Sujith J Chandy (1,2), Thomas.
Collecting data in clinic.  Aim of BADBIR  Definition of Adverse Events  Adverse events in BADBIR  Adverse event recording in hospital case notes.
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
Sex-Specific Chest Pain Characteristics in AMI Jay Mansfield, Pgy-3 July 22, 2014 LSU Journal Club Gimenez, M, et. Al. Jama Int Med. 2014;174(2):
Prospective Evaluation of B-type Natriuretic Peptide Concentrations and the Risk of Type 2 Diabetes in Women B.M. Everett, N. Cook, D.I. Chasman, M.C.
Approach To Pneumonia. Pneumonia Importance Mechanism Classification & its benefit Diagnosis Treatment.
INTRODUCTION Upper respiratory tract infections, including acute pharyngitis, are common in general practice. Although the most common cause of pharyngitis.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology.
Kimberly Dunbar, PA-S2 Follow-up of Cardiovascular Risk Markers in Hypertensive Patients Treated with Irbesartan: Results of the i-SEARCH Plus Registry.
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
Integrated Management of Childhood Illnesses
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
The Burden of Angina Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology March 25, 2009Journal Watch Cardiology In.
European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.
Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients Gradman AH, Parisé H, Lefebvre P, Falvey H, Lafeuille MH,
以多重死因資料比較台灣美國腦中風 併發吸入性肺炎之趨勢 奇美醫學中心 張嘉祐醫師. Stroke Statistics -- A Report From the American Heart Association Approximately 56% of stroke deaths in 2009.
Jan 2002 EDMA The central role of the Medical Laboratory in a World of Managed Health An EDMA presentation of the benefits of in vitro testing as a basis.
RESEARCH POSTER PRESENTATION DESIGN © Cardiac Troponin Assay Cardiac troponin I is the diagnostic marker used for myocardial.
Serum Natriuretic Peptide testing as part of the heart failure diagnostic pathway Candy Jeffries National Improvement Lead for Heart Failure.
Which troponin assay to choose? Clinical performances of troponin T and troponin I assays Per Venge, MD PhD Professor Department of Medical Sciences Uppsala.
Dr Michelle Webb Renal Consultant, Associate Medical Director Patient Safety, East Kent Hospitals University NHS Foundation Trust and Co-lead for Sepsis.
Women reaching equality in health, despite the differences Nowadays women remain the largest CAD population subgroup being under-diagnosed and under-treated.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
WELCOME BNP testing. Aims of this education package Better understanding of what BNP testing is How to appropriately use the test How to request the.
Published Date: 03 Aug 2015 No. of pages : 103 World Cardiac Biomarkers - Market.
Antibiotics: handle with care!
Published on – 1 August, 2015 | Number of pages : 103
Evidence-based Medicine
Tobias Reichlin, M. D. , Willibald Hochholzer, M. D
Knowledge l Action l Impact
Cardiac Biomarkers.
Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.
European Heart Association Journal 2007 April
Biomarker-Guided HF Therapy: Is It Cost-Effective?
Improving Antibiotic use through a Nationwide Decentralized Project –
Recognising sepsis and taking action
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
The Research Question Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are associated with many adverse outcomes HF and AF share.
Illustrative Performance Improvement Targets
Presentation transcript:

How can new diagnostic methods contribute in healthcare? What are doctors looking for? Better support in their clinical decision makings, which includes: o more accurate diagnosis o reliable prognostic estimation o tools for therapy stratification and monitoring Rapid answers to the patient in order to: o reduce the need for later reevaluation of the patient o provide the patient with maximal information at the doctor´s visit

How can new diagnostic methods contribute in healthcare? What are doctors looking for? 1. More accurate diagnostic and prognostic markers in cardio-vascular disease 2. Markers for the distinction between bacterial and viral causes of acute infections 3. And more

Heart disease accounts for 49% of all deaths in Europe The estimated cost for the society in Europe is 169 billion euros

Cardiac troponins in a healthy population – the impact of an ultra-sensitive troponin assay 99 th percentile URL 99 th percentile <60 y

ULSAM-study U ppsala L ongitudinal S tudy of A dult M en All men in Uppsala born between 1920 and 1924 All 50 years old men (n=2841) were invited for the investigation, 81.7% (n=2322) participated Remaining cohort at 70 years of age n =1673 (73% participated n=1221) – Men without cardiovascular disease disease n = 853 – Men with cardiovascular disease n = 368 Follow-up period 10.4 years

Thus, the development and use of ultra-sensitive troponin assays as indicators of myocardial dysfunction and leakage will enable us to identify many more subjects at risk of premature death in cardio-vascular disease

Heart failure – a deadly disease and a diagnostic dilemma Correct diagnosis – correct treatmentFalse diagnosis – wrong treatment Missed diagnosis – no treatment

Heart failure – the impact of assaying blood levels of natriuretic peptides (BNP and NT-proBNP) Correct diagnosis – correct treatmentFalse diagnosis – wrong treatment Missed diagnosis – no treatment

NT-proBNP in healthy 70-year old men in relation to all- cause death during a 10 year follow-up, n=839 (ULSAM) NT-proBNP, ng/L % Death

Should my patient be prescribed antibiotics or not? 49% of all patients visiting a primary health care unit in Sweden called the doctor because of symptoms of acute infection The clinical diagnosis of most respiratory infections such as pneumonia, pharyngitis/tonsillitis, otitis has, when based on symptoms and physical signs only, a diagnostic sensitivity and specificity of 55-60% in the distinction between a viral or bacterial cause of the infection

And how can we slow down the epidemics of antibiotics resistance?

Is the discovery of Human neutrophil lipocalin (HNL) the answer to our needs?

P-CRP S-HNL Specificity Sensitivity Discrimination between acute bacterial and viral infections Hospitalized adult population Highest diagnostic accuracy in left corner

Internists base their clinical management to 70-80% on laboratory tests Primary care doctors base their clinical management to 10-20% on laboratory tests Laboratory testing is an efficient means to save money in health care since it provides the doctor with: Some conclusions  more accurate diagnosis  more reliable prognostic estimation  better tools for therapy stratification and monitoring All for the benefit of our patients and the society